Coordination of a gene therapy program focused on adeno-associated viruses.
Official title: NATIONAL INSTITUTE OF HEALTH (NIH), NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES (NCATS), BESPOKE GENE THERAPY CONSORTIUM - COORDINATION CENTER
Funded at Black Canyon Consulting LLC · NIH-11176667 · Data updated 2026-11-12
This study is all about working together to create new gene therapies that could help people with genetic disorders, so if you're looking for exciting new treatment options, this could be for you!
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Black Canyon Consulting LLC NIH-funded |
| Lab location | 1 site (Fairfax, United States) |
| Project start | September 1, 2023 |
| Project end | August 31, 2026 |
| Funding year | 2024 |
| Award (this year) | $1,059,004 |
| NIH project number | 75N98022D00019-P00001-759802300006-1 |
| Project ID | NIH-11176667 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for participation or benefit are individuals with genetic disorders that may be addressed by adeno-associated virus gene therapies.
✕Less likely to help
Patients with conditions not related to genetic disorders or those who do not respond to gene therapy may not receive benefits from this research.
What this research studies
This research involves the coordination of the Bespoke Gene Therapy Consortium, which aims to advance gene therapy techniques using adeno-associated viruses. The project management office will oversee various clinical development teams working on gene therapy projects, ensuring effective collaboration and resource allocation. Patients may benefit from the innovative gene therapies being developed through this consortium, which could lead to new treatment options for genetic disorders.
Why it matters
Potential benefit: If successful, this research could lead to groundbreaking gene therapies that improve treatment outcomes for patients with genetic conditions.
How similar studies have gone: Previous research in gene therapy using adeno-associated viruses has shown promising results, indicating potential for success in this approach.
Where this research is happening
-
Black Canyon Consulting LLC
Fairfax, United States Active
Researchers
- Principal investigator: Esser, Haley — Black Canyon Consulting LLC
- Study coordinator: Esser, Haley
Related research
Other NIH-funded projects on the same topics.
-
Developing tools to fight antibiotic-resistant bacteria
This study is working on improving online tools that help scientists and doctors find and understand antibiotic-resistant bacteria, so they can better tackle infections that are hard to treat.
-
Coordination of a gene therapy program for personalized treatments
This study is all about bringing together experts to create personalized gene therapies that could help patients with specific genetic conditions, making sure everyone works well together to develop these innovative treatments.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.